Panhematin is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Panhematin is given by a doctor or nurse, not picked up at a pharmacy.

  1. Ask your care team or your plan what you’d pay before your visit.

Compare every option

Question
Brand namePanhematin
Authorized generichemin
Regular generichemin
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Panhematin?
The original
–
–

Brand nameThe maker’s card

RRD PS Copay Assistance Program

Savings card from Recordati Rare Diseases

Panhematin’s maker has a savings program. Its page doesn’t list a dollar amount.

Sign up on panhematin.com 

From the maker’s site, checked November 2, 2026. Check the maker’s page for who can use it.

Authorized genericNot sold

There isn’t one. An authorized generic is Panhematin itself, from the same company, sold without the brand name, and usually for less. For now Panhematin is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Panhematin is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

PANHEMATIN is a hemin for injection indicated for amelioration of recurrent attacks of acute intermittent porphyria temporally related to the menstrual cycle in susceptible women, after initial carbohydrate therapy is known or suspected to be inadequate.

Limitations of Use

  • Before administering PANHEMATIN, consider an appropriate period of carbohydrate loading (i.e., 400 g glucose/day for 1 to 2 days).
  • PANHEMATIN is not effective in repairing neuronal damage due to progression of porphyria attacks.

Source: the FDA label for Panhematin (Recordati Rare Diseases, Inc.), February 26, 2026. Full label on DailyMed 

Good to know